David J Venzon Selected Research

David J Venzon Research Topics

Disease

17	Neoplasms (Cancer) 10/2023 - 10/2004
10	Infections 01/2021 - 04/2009
8	Viremia 11/2020 - 09/2009
7	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 01/2002
4	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 01/2019
3	Plexiform Neurofibroma 10/2023 - 01/2020
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2023 - 01/2020
3	Body Weight (Weight, Body) 01/2020 - 10/2015
3	Multiple Myeloma 10/2019 - 07/2017
2	Bronchiolitis Obliterans Syndrome 01/2021 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Disease Progression 01/2020 - 01/2019
2	Hypoalbuminemia 10/2019 - 06/2013
1	Pain (Aches) 10/2023
1	Inflammation (Inflammations) 01/2023
1	Capillary Leak Syndrome 01/2023
1	Cancer Pain 11/2022
1	Residual Neoplasm 12/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Nausea 01/2020
1	Diarrhea 01/2020
1	Exanthema (Rash) 01/2020
1	Vomiting 01/2020
1	Paronychia 01/2020
1	Hyperbilirubinemia 10/2019
1	HIV Infections (HIV Infection) 10/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Monoclonal Gammopathy of Undetermined Significance 01/2018
1	Smoldering Multiple Myeloma 01/2018
1	Thymoma (Thymic Carcinoma) 11/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Thrombotic Microangiopathies 09/2014
1	Cardiac Arrhythmias (Arrythmia) 06/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2013
1	Cardiotoxicity 06/2013

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 01/2023 - 09/2009
6	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2004
5	AndrogensIBA 09/2023 - 12/2004
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2019
3	AZD 6244IBA 10/2023 - 01/2020
3	AntibodiesIBA 01/2021 - 01/2018
3	Human Serum Albumin FDA LinkGeneric 01/2020 - 10/2015
3	CytokinesIBA 01/2019 - 12/2010
3	AIDS VaccinesIBA 10/2018 - 01/2018
3	AntigensIBA 11/2016 - 09/2009
2	Immunotoxins (Immunotoxin)IBA 01/2023 - 12/2012
2	Lenalidomide (CC 5013)FDA Link 10/2019 - 07/2017
2	carfilzomibIBA 10/2019 - 07/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 07/2017
1	enzalutamideIBA 12/2021
1	SteroidsIBA 01/2021
1	Interferon Type IIBA 01/2021
1	pomalidomideIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	CD40 Ligand (CD40L)IBA 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	Broadly Neutralizing AntibodiesIBA 01/2019
1	Galactosylceramides (Galactocerebrosides)IBA 01/2019
1	GP 140IBA 10/2018
1	Complement System Proteins (Complement)IBA 10/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	InflammasomesIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Granzymes (Granzyme)IBA 01/2018
1	env Gene ProductsIBA 01/2018
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2018
1	B-Cell Maturation AntigenIBA 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Cancer VaccinesIBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	MesothelinIBA 11/2016
1	Surface Antigens (Surface Antigen)IBA 11/2016
1	discorhabdin HIBA 01/2016
1	makaluvamine FIBA 01/2016
1	discorhabdin LIBA 01/2016
1	discorhabdin WIBA 01/2016
1	discorhabdin BIBA 01/2016
1	LuciferasesIBA 01/2016
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 01/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2014
1	Cell ExtractsIBA 04/2014
1	TroponinIBA 06/2013
1	MagnesiumIBA 06/2013
1	romidepsin (FK228)FDA Link 06/2013
1	PotassiumIBA 06/2013
1	Histone Deacetylase InhibitorsIBA 06/2013
1	Immunoglobulin G (IgG)IBA 02/2013
1	Protons (Proton)IBA 11/2012

Therapy/Procedure

14	Therapeutics 09/2023 - 09/2006
3	Cell Transplantation 11/2023 - 01/2020
3	Transplantation 01/2022 - 01/2019
2	Aftercare (After-Treatment) 12/2021 - 11/2005
1	Homologous Transplantation 01/2019
1	Immunotherapy 01/2017
1	Castration 01/2017